ckd and semaglutide Long-term kidney outcomes of in obesity cardiovascular disease in the SELECT trial FLOW: Semaglutide Scores Big in

The weight trajectory matters

If your GP does not have much experience with GLP-1 treatment, you can ask for a referral to a specialist or a weight management clinic

Today, peptides are used in medications, skincare products and dietary supplements due to their ability to target specific biological processes with precision

Once absorbed, semaglutide binds to GLP-1 receptors throughout the body, mimicking the action of natural incretin hormones

Although experience with GLP-1 agonists in patients with obesity and inflammatory skin diseases is currently scarce, the promising results reported suggest they may offer a useful tool for managing obesity

If your PCN or practice needs support with obesity medicine workload, medication reviews or prescribing safety, we can help.